Alaunos Therapeutics Inc (TCRT)

1.905 -0.26 (-12.21%) USD  |  NASDAQ  |  Dec 31, 16:00
1.82 -0.08 (-4.46%) After-Hours: 20:00
More

Alaunos Therapeutics Research and Development Expense (Annual): 16.28M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for TCRT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Microbot Medical Inc 5.724M
SELLAS Life Sciences Group Inc 24.01M
Galectin Therapeutics Inc 32.13M
Oragenics Inc 15.49M
Anavex Life Sciences Corp 41.84M